Hybrid N-Glycan

CAS : 84182-21-8

Ref. 3D-OH15859

Informations sur le produit

• Nom: Hybrid N-Glycan
• Synonymes: Hybrid-type, bisected, N-linked glycanM5A1B N-GlycanMannopentaose-di-(N-acetylglucosamine), N-acetylglucosaminyl-bisecting-N-acety lglucosaminylGlcNAc(GlcNAc)Man5(GlcNAc)2, D-Glucose,O-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1® 4)-O-[O-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1® 2)-a-D-mannopyranosyl-(1® 3)]-O-[O-a-D-mannopyranosyl-(1® 3)-O-[a-D-mannopyranosyl-(1® 6)]-a-D-mannopyranosyl-(1® 6)]-O-b-D-mannopyranosyl-(1® 4)-O-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1® 4)-2-(acetylamino)-2-deoxy-
• CAS: 84182-21-8

Description

Hybrid N-glycans are glycan structures that contain both a high mannose and complex type oligosaccharide. Hybrid N-glycans are expressed on the surface of mammalian cells, and they can be found in human serum. Hybrid N-glycans have been shown to activate caspase 3 and induce apoptosis in some mouse models. They also have biological functions such as growth factor binding or antibody binding. Hybrid N-glycans may be involved in the activation of the immune system or in the development of cancerous tumors.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,641.49 g/mol
• Formule: C₆₂H₁₀₄N₄O₄₆
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder